
He loved research, but knew academia wasn't a sustainable path.
Medical Science Liaison shares how he went from a PhD in Pharmacology to connecting with clinicians and researchers across the biopharmaceutical industry.
Sharing stories and insights from 300+ interviews with PhDs who have transitioned to careers beyond academia
Live Last read · last published · next check

Medical Science Liaison shares how he went from a PhD in Pharmacology to connecting with clinicians and researchers across the biopharmaceutical industry.

Sam Kimmey, a Senior Scientist in Product Development at Ionpath, shares how he went from a PhD in Developmental Biology to developing cutting-edge tissue imaging technologies in biotech.

Director of Global Scientific Publications goes from PhD in Psychology to leading publications and communications for clinical-stage therapies.

Head of Business & Product goes from a PhD in Chemical Engineering to helping shape RNA-focused biotech strategy and partnerships.

Aimee Iberg, a Senior Director of Oncology Drug Discovery at Recursion, shares how she went from a PhD in Molecular Biology to leading cross-functional AI-enabled drug discovery teams.

Brandon McFarlin, a Medical Science Liaison at Ardelyx, shares how he went from a PhD in Medical Biology to building scientific partnerships and advancing patient care in nephrology.

Forrest Collman, an Associate Investigator at the Allen Institute for Brain Science, shares how he went from a PhD in Neuroscience and Molecular Biology to leading large-scale neuroscience research.

Bonnie EJ Maven, the Founder and CEO of Vertility Health, shares how she went from a PhD in Developmental & Stem Cell Biology to building technology in the fertility space.

Jessica Ribado, a Senior Research Scientist at the Bill and Melinda Gates Foundation, shares how she went from a PhD in Genetics to using data and models to inform global health decisions.

Jill Daigneault, a Regional Medical Director at Nuvation Bio, shares how she went from a PhD in Cancer Biology to working at the intersection of science, medicine, and patient impact.